Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$22.39M
↑ 108% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-295.79M
Historical baseline
PeriodValueYoY Change
TTM$22.39M+111.3%
2024$-197.88M+62.6%
2023$-528.63M+18.9%
2022$-652.17M+12.6%
2021$-746.35M-116.4%
2020$-344.87M-13.2%
2019$-304.71M-139.0%
2018$-127.50M-150.0%
2017$-51.01M-88.0%
2016$-27.13M-